• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉罗他赛在碱性条件下的降解动力学及其降解产物的鉴定

Degradation kinetics of larotaxel and identification of its degradation products in alkaline condition.

作者信息

Liang Xiaoming, Liu Zhenzhen, Shi Huiyan, Zhang Yuanyuan, Wang Shixiao, Bi Kaishun, Chen Xiaohui

机构信息

Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.

Department of Functional Science, School of Medicine, Yangtze University, No.1 Nanhuan Road, Jingzhou City 434100, China.

出版信息

J Pharm Anal. 2017 Apr;7(2):118-122. doi: 10.1016/j.jpha.2016.11.002. Epub 2016 Nov 19.

DOI:10.1016/j.jpha.2016.11.002
PMID:29404026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5686960/
Abstract

Larotaxel, a new taxane compound prepared by partial synthesis from 10-deacetyl baccatin III, is active against tumors. In this research, a selective LC-MS method was developed and validated for the study of degradation kinetics of larotaxel, which was carried out in aqueous solutions with different pH (1.5, 3.0, 5.0, 6.5, 7.4, 9.0, 10 and 11.0) and temperature (0, 25, 37 and 45 °C). The linear range was 0.5-25 μg/mL, the intra- and inter-day precisions were less than 7.0%, and accuracy ranged from 97.4-104.5% for each analyte. The observed rate obtained by measuring the remaining intact larotaxel was shown to follow first-order kinetics. The activation energies for degradation were 126.7 and 87.01 kJ/mol at pH 1.5 and 11, respectively. Although larotaxel was stable in pH 5, 6.5 and 7.4 buffers at 37 °C for 24 h during our study, increasing or decreasing the pH of the solutions would decrease its stabilities. Moreover, three main degradation products in alkaline condition were separated by HPLC and identified by Q-TOF-MS. The three degradation products were confirmed as 10-deacetyl larotaxel, 7, 8-cyclopropyl baccatin Ⅲ and 10-deacetyl-7, 8-cyclopropyl baccatin Ⅲ.

摘要

拉罗他赛是一种通过对10-去乙酰浆果赤霉素III进行部分合成制备的新型紫杉烷化合物,具有抗肿瘤活性。在本研究中,开发并验证了一种选择性液相色谱-质谱法,用于研究拉罗他赛在不同pH值(1.5、3.0、5.0、6.5、7.4、9.0、10和11.0)和温度(0、25、37和45℃)的水溶液中的降解动力学。线性范围为0.5 - 25μg/mL,日内和日间精密度均小于7.0%,各分析物的准确度范围为97.4 - 104.5%。通过测量剩余完整拉罗他赛获得的观测速率显示遵循一级动力学。在pH 1.5和11时,降解的活化能分别为126.7和87.01kJ/mol。尽管在我们的研究中,拉罗他赛在37℃的pH 5、6.5和7.4缓冲液中24小时内稳定,但溶液pH值的升高或降低都会降低其稳定性。此外,通过高效液相色谱分离并通过Q-TOF-MS鉴定了碱性条件下的三种主要降解产物。这三种降解产物被确认为10-去乙酰拉罗他赛、7,8-环丙基浆果赤霉素Ⅲ和10-去乙酰-7,8-环丙基浆果赤霉素Ⅲ。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/d6dd7b6ad869/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/7d64548e1833/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/585f718d0282/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/c1e30e3186cf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/8057e1d1eabc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/d6dd7b6ad869/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/7d64548e1833/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/585f718d0282/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/c1e30e3186cf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/8057e1d1eabc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/5686960/d6dd7b6ad869/gr5.jpg

相似文献

1
Degradation kinetics of larotaxel and identification of its degradation products in alkaline condition.拉罗他赛在碱性条件下的降解动力学及其降解产物的鉴定
J Pharm Anal. 2017 Apr;7(2):118-122. doi: 10.1016/j.jpha.2016.11.002. Epub 2016 Nov 19.
2
Isolation and characterization of process-related impurities and degradation products in larotaxel.拉罗他赛中工艺相关杂质及降解产物的分离与特性鉴定。
J Pharm Biomed Anal. 2011 Jul 15;55(5):1190-6. doi: 10.1016/j.jpba.2011.03.036. Epub 2011 Apr 6.
3
Degradation kinetics of water-insoluble lauroyl-indapamide in aqueous solutions: prediction of the stabilities of the drug in liposomes.水不溶性月桂酰吲达帕胺在水溶液中的降解动力学:药物在脂质体中的稳定性预测
Arch Pharm Res. 2007 Jul;30(7):876-83. doi: 10.1007/BF02978840.
4
Development of a UPLC-ESI-MS/MS method for the determination of larotaxel in beagle dog plasma: application to the pharmacokinetic study.建立 UPLC-ESI-MS/MS 法测定比卡鲁胺在比格犬血浆中的浓度: 应用于药代动力学研究。
Anal Bioanal Chem. 2012 Apr;403(1):323-30. doi: 10.1007/s00216-012-5763-7.
5
Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics.紫杉醇及其相关化合物在水溶液中的降解 III:酸性 pH 条件下的降解和总体动力学。
J Pharm Sci. 2010 Mar;99(3):1288-98. doi: 10.1002/jps.21910.
6
Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS.用一种新型的稳定性指示液相色谱法研究卡博替尼的降解动力学,并通过液相色谱/飞行时间质谱和液相色谱-串联质谱鉴定其主要降解产物。
J Pharm Biomed Anal. 2014 Sep;98:356-63. doi: 10.1016/j.jpba.2014.06.008. Epub 2014 Jun 12.
7
[Spectrometric analyses of larotaxel and larotaxel liposomes quantification by high performance liquid chromatography].[通过高效液相色谱法对拉罗他赛及拉罗他赛脂质体进行光谱分析定量]
Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Jun 18;51(3):467-476. doi: 10.19723/j.issn.1671-167X.2019.03.014.
8
Kinetics of abiotic hydrolysis of isoxaflutole: influence of pH and temperature in aqueous mineral buffered solutions.异恶唑草酮的非生物水解动力学:pH值和温度对水性矿物缓冲溶液的影响
J Agric Food Chem. 2000 Sep;48(9):4399-403. doi: 10.1021/jf991247m.
9
Analysis of neem oils by LC-MS and degradation kinetics of azadirachtin-A in a controlled environment. Characterization of degradation products by HPLC-MS-MS.印楝油的液相色谱-质谱分析及印楝素A在可控环境中的降解动力学。通过高效液相色谱-串联质谱对降解产物进行表征。
Anal Bioanal Chem. 2004 Feb;378(3):753-63. doi: 10.1007/s00216-003-2377-0. Epub 2003 Dec 18.
10
Degradation kinetics of gonadorelin in aqueous solution.促性腺激素释放激素在水溶液中的降解动力学
J Pharm Sci. 1996 Oct;85(10):1053-9. doi: 10.1021/js9601187.

引用本文的文献

1
Determination of solubility, stability and degradation kinetics of morin hydrate in physiological solutions.水合桑色素在生理溶液中的溶解度、稳定性及降解动力学测定
RSC Adv. 2018 Aug 14;8(50):28836-28842. doi: 10.1039/c8ra04139c. eCollection 2018 Aug 7.
2
Kinetics of CBD, Δ-THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions.在不同温度和 pH 值条件下,大麻树脂中 CBD、Δ-THC 降解和大麻醇形成的动力学。
Cannabis Cannabinoid Res. 2022 Aug;7(4):537-547. doi: 10.1089/can.2021.0004. Epub 2021 Jun 4.

本文引用的文献

1
Determination of larotaxel and its metabolites in rat plasma by liquid chromatography-tandem mass spectrometry: application for a pharmacokinetic study.液相色谱-串联质谱法测定大鼠血浆中拉罗他赛及其代谢物:在药代动力学研究中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Feb 1;947-948:132-8. doi: 10.1016/j.jchromb.2013.12.029. Epub 2013 Dec 31.
2
pH and temperature effects on the hydrolysis of three β-lactam antibiotics: ampicillin, cefalotin and cefoxitin.pH 和温度对三种β-内酰胺类抗生素(氨苄青霉素、头孢噻吩和头孢西丁)水解的影响。
Sci Total Environ. 2014 Jan 1;466-467:547-55. doi: 10.1016/j.scitotenv.2013.06.027. Epub 2013 Aug 13.
3
Isolation and characterization of process-related impurities and degradation products in larotaxel.
拉罗他赛中工艺相关杂质及降解产物的分离与特性鉴定。
J Pharm Biomed Anal. 2011 Jul 15;55(5):1190-6. doi: 10.1016/j.jpba.2011.03.036. Epub 2011 Apr 6.
4
Larotaxel: broadening the road with new taxanes.拉罗他赛:新型紫杉烷拓宽道路。
Expert Opin Investig Drugs. 2009 Aug;18(8):1183-9. doi: 10.1517/13543780903119167.
5
Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours.拉罗他赛每3周1小时静脉输注给药用于日本晚期实体瘤患者的I期研究。
Cancer Chemother Pharmacol. 2009 Dec;65(1):129-36. doi: 10.1007/s00280-009-1014-9. Epub 2009 May 13.
6
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.拉罗他赛(XRP9881)联合顺铂或吉西他滨作为不可放疗的IIIB期或IV期非小细胞肺癌一线化疗的随机多中心II期研究。
J Thorac Oncol. 2008 Aug;3(8):894-901. doi: 10.1097/JTO.0b013e31817e6669.
7
Degradation kinetics of water-insoluble lauroyl-indapamide in aqueous solutions: prediction of the stabilities of the drug in liposomes.水不溶性月桂酰吲达帕胺在水溶液中的降解动力学:药物在脂质体中的稳定性预测
Arch Pharm Res. 2007 Jul;30(7):876-83. doi: 10.1007/BF02978840.
8
Strategies for the investigation and control of process-related impurities in drug substances.原料药中与工艺相关杂质的调查与控制策略。
Adv Drug Deliv Rev. 2007 Jan 10;59(1):12-28. doi: 10.1016/j.addr.2006.10.005. Epub 2006 Nov 15.
9
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors.以1小时或3小时输注方式给药的紫杉烷衍生物RPR 109881A在晚期实体瘤患者中的I期临床和药代动力学研究。
Ann Oncol. 2002 Jul;13(7):1140-50. doi: 10.1093/annonc/mdf174.
10
Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors.新型紫杉烷类化合物RPR 109881A在晚期实体瘤患者中进行1小时静脉输注的I期及药代动力学研究。
J Clin Oncol. 2000 Sep;18(17):3164-71. doi: 10.1200/JCO.2000.18.17.3164.